Cell and Organ Transplantology. 2022; 10(1):26-35.
DOI: 10.22494/cot.v10i1.135
Structural changes of spinal cord tissue of rats with experimental spinal cord injury after the implantation of fibrin matrix associated with neural and mesenchymal progenitor cells
Liubich L.1
, Staino L.1
, Egorova D.1
, Medvediev V.2
, Oleksenko N.1
, Verbovska S.1, Pichkur L.1
, Tsymbaliuk V.3![]()
- 1The State Institution “Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
- 2Bohomolets National Medical University, Kyiv, Ukraine
- 3National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine, Kyiv, Ukraine
Abstract
Spinal cord injury (SCI) is one of the most common severe injuries to the central nervous system, resulting in motor dysfunction and sensory loss. Cell therapy using stem/progenitor cells (SCs/PCs), regenerative biomaterials, tissue engineering technologies and their combinations is a promising area of regenerative medicine for the treatment of this pathology.
The purpose of the research was to study the effect of implantation of fibrin matrix (FM) associated with rat neonatal brain cells (rNBCs) or human mesenchymal stromal cells of Wharton’s jelly (hWJ-MSCs) on the recovery process of rat spinal cord (SC) tissue after lateral hemisection in the lower thoracic-upper lumbar region.
Materials and methods. Four experimental groups were formed: 1) comparison group – SCI without additional treatment (self-recovery); 2) SCI + implantation of cell-free FM fragment in the injury area (SCI + FM); 3) SCI + implantation of FM with incorporated hWJ-MSCs (1·106/ml) in the injury area (SCI + FM + hWJ-MSCs), 4) SCI + implantation of FM with incorporated rNBCs (1·106/ml) in the injury area (SCI + FM + rNBCs). The fragments of the SC tissue for morphological examination were obtained in the long-term period (7-9 months) after SCI. Serial longitudinal thin 5-7 μm sections of the tissue were prepared and immunohistochemical and morphometric studies were performed.
Results. In the long-term period after SCI, the traumatic cavity is replaced by elements of glia and connective tissue. A fragment of cell-free FM implanted in the traumatic area serves as a structural framework that creates a niche for cell migration (gliocytes, neural SCs/PCs (NSCs/NPCs) and, possibly, endogenous regeneration of the defect thanks to its own NSCs/NPCs; in the perifocal zone around the traumatic area, there is an increase in dystrophic changes in neurons, the formation of a gliofibrous capsule. The FM, associated with the hWJ-MSCs and implanted in the traumatic cavity, creates the conditions for hWJ-MSCs survival and, probably, their initial differentiation in the glial direction; incorporated hWJ-MSCs have a neuroprotective effect on the neurons of the perifocal zone, which can serve as a basis for the restoration of SC functions. The FM, associated with the rNBCs and implanted in the traumatic cavity, creates conditions for the structural recovery of SC tissue (replacement by terminally differentiated astrocytes and neurons); incorporated rNBCs have a neuroprotective effect on the neurons of the perifocal zone, which can be the basis for the functional recovery of SC.
Conclusions. Implantation of FM associated with hWJ-MSCs or rNBCs is more effective, compared to the cell-free analogue, in terms of structural recovery of SC and neuroprotective effect after its traumatic transection.
Key words: spinal cord injury; fibrin matrix; neural stem/progenitor cells; multipotent mesenchymal stromal cells; regeneration; neuroprotection
Full Text PDF| 1. Liu S, Xie YY, Wang B. Role and prospects of regenerative biomaterials in the repair of spinal cord injury. Neural Regen Res. 2019; 14:1352-63. http://www.nrronline.org/text.asp?2019/14/8/1352/253512. https://doi.org/10.4103/1673-5374.253512 PMid:30964053 PMCid:PMC6524500 |
||||
| 2. National Spinal Cord Injury Statistical Center, Facts and Figures at a Glance. Birmingham, AL: University of Alabama at Birmingham, 2021. https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%202020.pdf. | ||||
| 3. Furlan JC, Craven BC, Massicotte EM, et al. Early versus delayed surgical decompression of spinal cord after traumatic cervical spinal cord injury: a cost-utility analysis. World Neurosurg. 2016; 88: 166-174. doi: 10.1016/j.wneu.2015.12.072. https://doi.org/10.1016/j.wneu.2015.12.072 PMid:26773983 |
||||
| 4. Kabu S, Gao Y, Kwon BK, et al. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release. 2015; 219:141-154. doi: 10.1016/j.jconrel.2015.08.060. https://doi.org/10.1016/j.jconrel.2015.08.060 PMid:26343846 PMCid:PMC4656085 |
||||
| 5. Agbay A, Edgar JM, Robinson M, et al. Biomaterial strategies for delivering stem cells as a treatment for spinal cord injury. Cells Tissues Organs. 2016; 202:42-51. doi: 10.1159/000446474. https://doi.org/10.1159/000446474 PMid:27701166 |
||||
| 6. Kang SK, Shin IS, Ko MS, Jo JY, Ra JC. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012; 2012:342968. doi: 10.1155/2012/342968. https://doi.org/10.1155/2012/342968 PMid:22754575 PMCid:PMC3382267 |
||||
| 7. Yarar E, Kuruoglu E, Kocabicak E, et al. Electrophysiological and histopathological effects of mesenchymal stem cells in treatment of experimental rat model of sciatic nerve injury. Int J Clin Exp Med. 2015; 8:8776-84. PMID: 26309529 PMCID: PMC4537965. | ||||
| 8. Yao S, Yu S, Cao Z, et al. Hierarchically aligned fibrin nanofiber hydrogel accelerated axonal regrowth and locomotor function recovery in rat spinal cord injury. Int J Nanomedicine. 2018; 13:2883-2895. doi: 10.2147/IJN.S159356. https://doi.org/10.2147/IJN.S159356 PMid:29844671 PMCid:PMC5961640 |
||||
| 9. Wang J, Zheng J, Zheng Q, et al. FGL-functionalized self-assembling nanofiber hydrogel as a scaffold for spinal cord-derived neural stem cells. Mater Sci Eng C Mater Biol. 2015; 46:140-147. doi: 10.1016/j.msec.2014.10.019. https://doi.org/10.1016/j.msec.2014.10.019 PMid:25491970 |
||||
| 10. Kubinová S, Syková E. Nanotechnologies in regenerative medicine. Minim Invasive Ther Allied Technol. 2010; 19(3):144-56. doi: 10.3109/13645706.2010.481398. PMID: 20497067. https://doi.org/10.3109/13645706.2010.481398 PMid:20497067 |
||||
| 11. Shrestha B, Coykendall K, Li Y, et al. Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res Ther. 2014;5(91) https://doi.org/10.1186/scrt480 https://doi.org/10.1186/scrt480 PMid:25157690 PMCid:PMC4282172 |
||||
| 12. Pang M, Shu T, Chen RQ, et al. Neural precursor cells generated from induced pluripotent stem cells with gelatin sponge-electrospun PLGA/PEG nanofibers for spinal cord injury repair. Int J Clin Exp Med. 2016; 9:17985-17994. | ||||
| 13. Yang L, Chueng SD, Li Y, et al. A biodegradable hybrid inorganic nanoscaffold for advanced stem cell therapy. Nat Commun. 2018; 9:3147. https://doi.org/10.1038/s41467-018-05599-2. https://doi.org/10.1038/s41467-018-05599-2 PMid:30089775 PMCid:PMC6082841 |
||||
| 14. Zhang G, Khan AA, Wu H, et al. The application of nanomaterials in stem cell therapy for some neurological diseases. Curr Drug Targets. 2018; 19:279-298. doi: 10.2174/1389450118666170328115801. https://doi.org/10.2174/1389450118666170328115801 PMCid:PMC5581292 |
||||
| 15. Slaughter BV, Khurshid SS, Fisher OZ, et al. Hydrogels in regenerative medicine. Adv Mater. 2009; 21(32-33):3307-29. doi: 10.1002/adma.200802106. PMID: 20882499; PMCID: PMC4494665. https://doi.org/10.1002/adma.200802106 PMid:20882499 PMCid:PMC4494665 |
||||
| 16. Wen Y, Yu S, Wu Y, et al. Spinal cord injury repair by implantation of structured hyaluronic acid scaffold with PLGA microspheres in the rat. Cell Tissue Res. 2016; 364:17- 28. doi: 10.1007/s00441-015-2298-1 https://doi.org/10.1007/s00441-015-2298-1 PMid:26463048 |
||||
| 17. Ortiz AdC, Fideles SOM, Pomini KT, et al. Potential of Fibrin Glue and Mesenchymal Stem Cells (MSCs) to Regenerate Nerve Injuries: A Systematic Review. Cells. 2022; 11(2):221. https://doi.org/10.3390/cells11020221. https://doi.org/10.3390/cells11020221 PMid:35053336 PMCid:PMC8773549 |
||||
| 18. Sudhadevi T, Vijayakumar HS, Hariharan EV, et al. Optimizing fibrin hydrogel toward effective neural progenitor cell delivery in spinal cord injury. Biomed Mater. 2021; 17(1). doi: 10.1088/1748-605X/ac3680. PMID: 34736245. https://doi.org/10.1088/1748-605X/ac3680 PMid:34736245 |
||||
| 19. Yousefifard M, Nasseri Maleki S, Askarian-Amiri S, et al. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019; 32(2):269-284. doi: 10.3171/2019.8.SPINE19201. PMID: 31675724. https://doi.org/10.3171/2019.8.SPINE19201 PMid:31675724 |
||||
| 20. Pan HC, Cheng FC, Lai SZ, et al. Enhanced regeneration in spinal cord injury by concomitant treatment with granulocyte colony-stimulating factor and neuronal stem cells. J Clin Neurosci. 2008; 15(6):656-64. doi: 10.1016/j.jocn.2007.03.020. PMID: 18406145. https://doi.org/10.1016/j.jocn.2007.03.020 PMid:18406145 |
||||
| 21. Mukhamedshina YO, Akhmetzyanova ER, Kostennikov AA, et al. Adipose-Derived Mesenchymal Stem Cell Application Combined with Fibrin Matrix Promotes Structural and Functional Recovery Following Spinal Cord Injury in Rats. Front Pharmacol. 2018; 9:343. doi:10.3389/fphar.2018.00343. https://doi.org/10.3389/fphar.2018.00343 PMid:29692732 PMCid:PMC5902567 |
||||
| 22. Mukhamedshina Y, Shulman I, Ogurcov S, et al. Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models. Biomolecules. 2019; 9(12). pii: E811. doi: 10.3390/biom9120811. https://doi.org/10.3390/biom9120811 PMid:31805639 PMCid:PMC6995633 |
||||
| 23. Masgutov R, Masgutova G, Mullakhmetova A, et al. Adipose-Derived Mesenchymal Stem Cells Applied in Fibrin Glue Stimulate Peripheral Nerve Regeneration. Front Med (Lausanne). 2019; 6:68. doi:10.3389/fmed.2019.00068). https://doi.org/10.3389/fmed.2019.00068 PMid:31024916 PMCid:PMC6465797 |
||||
| 24. ClinicalTrials.gov http://www: clinicaltrials.gov | ||||
| 25. Tsymbaliuk V, Deriabina E, Shuvalova N, et al. Phenotypical changes and proliferative potential of mesenchymal stem cells from humans Wharton’s jelly in the cultivation conditions. Ukranian Neurosurgical Journal. 2015;(2):17-24. doi: 10.25305/unj.45290 https://doi.org/10.25305/unj.45290 |
||||
| 26. Medvediev VV, Oleksenko NP, Pichkur LD et al. Effect of Implantation of a Fibrin Matrix Associated with Neonatal Brain Cells on the Course of an Experimental Spinal Cord Injury. Cytol. Genet. 2022; 56: 125-138. https://doi.org/10.3103/S0095452722020086. https://doi.org/10.3103/S0095452722020086 |
||||
| 27. Medvediev VV, Abdallah IM, Draguntsova NG, et al. Model of spinal cord lateral hemi-excision at the lower thoracic level for the tasks of reconstructive and experimental neurosurgery. Ukr Neurosurg J. 2021; 27(3):33-5. https://doi.org/10.25305/unj.234154. https://doi.org/10.25305/unj.234154 |
||||
| 28. Jeong HJ, Yun Y, Lee SJ et al. Biomaterials and strategies for repairing spinal cord lesions. Neurochemistry International. 2021; 144:104973. doi: 10.1016/j.neuint.2021.104973 https://doi.org/10.1016/j.neuint.2021.104973 PMid:33497713 |
||||
| 29. Burns AS, Marino RJ, Kalsi-Ryan S, et al. Type and Timing of Rehabilitation Following Acute and Subacute Spinal Cord Injury: A Systematic Review. Global Spine J. 2017; 7(3 Suppl):175S-194S. doi: 10.1177/2192568217703084. PMID: 29164023; PMCID: PMC5684843. https://doi.org/10.1177/2192568217703084 PMid:29164023 PMCid:PMC5684843 |
||||
| 30. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452-458. doi: 10.1038/bmt.2012.244. PMID: 23208313; PMCID: PMC3590441. https://doi.org/10.1038/bmt.2012.244 PMid:23208313 PMCid:PMC3590441 |
||||
| 31. Libro R, Bramanti P, Mazzon E. The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration. Exp Ther Med. 2017; 14:3355-3368. doi: 10.3892/etm.2017.4939. PMID: 29042919; PMCID: PMC5639409. https://doi.org/10.3892/etm.2017.4939 PMid:29042919 PMCid:PMC5639409 |
||||
| 32. Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organisation. Histology and Histopathology. 2005; 20(2): 665-71. PMID 15736068. | ||||
| 33. Lööv C, Hillered L, Ebendal T, et al. Engulfing Astrocytes Protect Neurons from Contact-Induced Apoptosis following Injury. PLoS ONE. 2012; 7(3): e33090. https://doi.org/10.1371/journal.pone.0033090. https://doi.org/10.1371/journal.pone.0033090 PMid:22461890 PMCid:PMC3312890 |
||||
| 34. Lööv C, Shevchenko G, Nadadhur AG, et al. Identification of injury specific proteins in a cell culture model of traumatic brain injury. PLoS One. 2013; 8(2): e55983. DOI:10.1371/journal.pone.0055983. https://doi.org/10.1371/journal.pone.0055983 PMid:23409102 PMCid:PMC3567017 |
||||
| 35. Chen JY, Mou XZ, Du XZ, et al. Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins. Asian Pac J Trop Med. 2015; 8(9):739-46. doi: 10.1016/j.apjtm.2015.07.022. PMID: 26433660. https://doi.org/10.1016/j.apjtm.2015.07.022 PMid:26433660 |
||||
| 36. Abumaree MH, Al Saad K, Aldlamy M, et al. Human placental mesenchymal stem cells (pMSCs) modulate the immunopathogenesis process in experimental autoimmune encephalomyelitis (EAE). ECTRIMS Online Library. 2015, 2015;115237. Available from: https://onlinelibrary.ectrims-congress.eu/ectrims/2015/31st/115237/mohammed. abuma-ree.human.placental.mesenchymal.stem.cells.28pmscs29.modulate.the.html?f=m1. | ||||
| 37. Laroni A, Kerlego de Rosbo N, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: immunoregulation beyond neuroprotection. Immunology letter. 2015;168:183-190. http://dx.doi.org/10.1016/j.imlet.2015.08.007. https://doi.org/10.1016/j.imlet.2015.08.007 PMid:26296458 |
||||
| 38. Konala VB, Mamidi MK, Bhonde R, et al. The current landscape of the mesenchymal stromal cell secretome. Cytotherapy. 2016;18:13-24. DOI:10.1016/j.jcyt.2015.10.008. https://doi.org/10.1016/j.jcyt.2015.10.008 PMid:26631828 PMCid:PMC4924535 |
||||
Liubich L, Staino L, Egorova D, Medvediev V, Oleksenko N, Verbovska S, Pichkur L, Tsymbaliuk V. Structural changes of spinal cord tissue of rats with experimental spinal cord injury after the implantation of fibrin matrix associated with neural and mesenchymal progenitor cells. Cell Organ Transpl. 2022; 10(1):26-35. Available from: https://doi.org/10.22494/cot.v10i1.135
![]()
Is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)

